GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » EV-to-Revenue

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) EV-to-Revenue : 2.78 (As of Apr. 25, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Aspen Pharmacare Holdings's enterprise value is $6,354 Mil. Aspen Pharmacare Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,285 Mil. Therefore, Aspen Pharmacare Holdings's EV-to-Revenue for today is 2.78.

The historical rank and industry rank for Aspen Pharmacare Holdings's EV-to-Revenue or its related term are showing as below:

APNHY' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.99   Med: 3.32   Max: 7.79
Current: 2.78

During the past 13 years, the highest EV-to-Revenue of Aspen Pharmacare Holdings was 7.79. The lowest was 1.99. And the median was 3.32.

APNHY's EV-to-Revenue is ranked worse than
58.44% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs APNHY: 2.78

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Aspen Pharmacare Holdings's stock price is $11.29. Aspen Pharmacare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.14. Therefore, Aspen Pharmacare Holdings's PS Ratio for today is 2.20.


Aspen Pharmacare Holdings EV-to-Revenue Historical Data

The historical data trend for Aspen Pharmacare Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings EV-to-Revenue Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 2.99 2.39 2.02 2.46

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.02 - 2.46 -

Competitive Comparison of Aspen Pharmacare Holdings's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's EV-to-Revenue falls into.



Aspen Pharmacare Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Aspen Pharmacare Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6354.116/2284.744
=2.78

Aspen Pharmacare Holdings's current Enterprise Value is $6,354 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aspen Pharmacare Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,285 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings  (OTCPK:APNHY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Aspen Pharmacare Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=11.29/5.143
=2.20

Aspen Pharmacare Holdings's share price for today is $11.29.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $5.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019